Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.

Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.

The synthetic version of THC was associated with a 30% reduction in symptoms of agitation with none of the adverse effects seen with current treatments.

Less than 15% of women with menopause receive treatment for VMS, suggesting a need a for more education and awareness, according to JoAnn Pinkerton, MD.

Albuterol/budesonide (Airsupra) has now proven effective as novel combination as-needed rescue medication for adults with asthma regardless of disease severity.

Your daily dose of the clinical news you may have missed.

Medicare’s restrictive coverage policies are denying patients with early Alzheimer's disease access to novel treatments. And private payers are following suit.

Increases in CRC screening were higher in high socioeconomic status and metropolitan areas, according to a new large cohort study.

An expert discussion with JoAnn Pinkerton, MD, national lead for the OASIS clinical trial program of elinzanetant for moderate-to-severe VMS.

Cologuard Plus bests its previous iteration and demonstrates greater sensitivity and specificity for any CRC relative to fecal immunochemical tests.